Kaplan–Meier survival analysis showed that miR‐500a‐3p predicted poor prognosis in patients with HCC, whereas α‐SMA showed no difference in predicting prognosis (Figure 1H). This evidence concerns the gene ACTA1 and hepatocellular carcinoma.